Menu

First Documented Case of Transgender Mother Breastfeeding

Doctors report that a regimen of hormones, an antiemetic drug, and pumping gave the woman enough milk production to feed her baby exclusively breastmilk for six weeks.

Feb 15, 2018
Kerry Grens

ISTOCK, SWEETLEMONTEATwo New York physicians report that, for the first time, a transgender woman has been able to breastfeed her child, and did so for six weeks.

The 30-year-old patient of theirs took hormones and an anti-nausea medication for three months, after which she was producing eight ounces of milk per day, the doctors reported in Transgender Health this January. Two weeks later, her partner gave birth and the baby’s growth and development progressed well during six weeks of exclusive breastfeeding from the transgender mom, after which the parents began supplementing with formula.

“There have been self-reported cases online of transgender women trying DIY regiments to induce breastfeeding, but this is the first case of induced functional lactation in the academic literature,” one of the doctors, Tamar Reisman of Mount Sinai hospital, tells The Guardian.

Boston Medical Center’s Joshua Safer, who did not treat the mom, tells New Scientist that transgender women tend to have “good breast development,” and that it’s not surprising this individual would be able to produce milk with the tissue. “This is very special. It will be very important for the many transgender women who want to breastfeed but do not feel they have the opportunity to do so.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.